Consiliul de administrație al Health Italia examinează unele date economice consolidate la 30 septembrie 2023
THE BOARD OF DIRECTORS OF HEALTH ITALIA S.P.A. HAS EXAMINED SOME CONSOLIDATED ECONOMIC DATA AS AT 30 SEPTEMBER 2023
PROFITABILITY UP STRONGLY AT +13% AND REVENUES IN LINE WITH Q3 2022
CONSOLIDATED SUMMARY DATA
NET REVENUE STABLE: € 25.1 MILLION (€ 25.3 MILLION)
EBITDA UP: € 4.1 MILLION, +13.1% YOY (€ 3.7 MILLION) EBITDA MARGIN 16.5% (14.5%)
Formello (RM), 17 november 2023 – The Board of Directors of Health Italia S.p.A. (EGM: HI) – one of the leading Italian leaders in the Italian market for supplementary healthcare and welfare and wellness solutions for families and employees of companies – met today to examine some unaudited consolidated financial data as at 30 September 2023.
The constant commitment to the search for new welfare solutions, a scrupulous cost management policy and concentration on the core business, have contributed to the achievement of an excellent performance in terms of both business and income, in line with the Group’s declared path of evolution and growth.
Net Revenues stood at €25.1 million, in line (-0.7%) compared to the same period of the previous year (€25.3 million). This trend, due to the deconsolidation of the Nutraceuticals and Real Estate divisions in the reference period 2023, was effectively balanced by the increase in revenues in the „core” Business Units.
The „Healthcare and Services” division contributes 73.1% to Net Revenues, while the „Medical Services” division contributes 26.9%.
EBITDA amounted to €4.1 million, with a significant growth of 13.1% compared to €3.7 million in 3Q 2022. EBITDA Margin stood at 16.5% of net revenues, recording growth by approximately 2 percentage points compared to the third quarter of 2022 (14.5%).
This data does not include the results of Be Health and Health Property, which were included as of September 30, 2022.
Livia Foglia, CEO of Health Italia, commented: “In the first 9 months of the year, the results indicate an improvement in margins compared to the previous year. This increase is attributable to the excellent performance of the core Healthcare and Services division as well as the correct balance between the implementation of a company policy oriented towards saving and the strategy of targeted investments in strategic infrastructures capable of increasing our level of competitiveness. The results, in line with the company’s expectations, demonstrate the solidity of our business model and support our strategic decision to focus on the core divisions, maximizing growth opportunities and ensuring excellent operational efficiency.”
